Submitted:
18 August 2023
Posted:
21 August 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
Ethical Statement
Study area
Data collection
Serological testing
Statistical analysis
3. Results
Study population
Sero-epidemiological analysis
Gender and age distribution of IgM and IgG HEV positive cases
Overlapping IgM and IgG distribution and evolution pattern from 2012 to 2014.
4. Discussion
Author Contributions
Funding
Acknowledgments
References
- WHO. Epidemiological update: increasing mortality calls for action 03. Global hepatitis report, 2017 7–20 (2017).
- Hepatitis E. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e.
- Ranger-Rogez, S., Alain, S. & Denis, F. Virus des hépatites : transmission mère-enfant. Pathologie Biologie 50, 568–575 (2002).
- Chandra, V., Taneja, S., Kalia, M. & Jameel, S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci 33, 451–464 (2008).
- Devi, S. G., Kumar, A., Kar, P., Husain, S. A. & Sharma, S. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol 86, 1366–1376 (2014).
- Fiore, S. & Savasi, V. Treatment of viral hepatitis in pregnancy. 10, 2801–2809 (2009). [CrossRef]
- Ornoy, A. & Tenenbaum, A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reproductive Toxicology 21, 446–457 (2006).
- Reyes, G. R. et al. Isolation of a cDNA from the Virus Responsible for Enterically Transmitted Non-A, Non-B Hepatitis. Science (1979) 247, 1335–1339 (1990).
- Schlauder, G. G. & Mushahwar, I. K. Genetic heterogeneity of hepatitis E virus*. J Med Virol 65, 282–292 (2001).
- Mushahwar, I. K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80, 646–658 (2008).
- Aggarwal, R. & Naik, S. Epidemiology of hepatitis E: Current status. J Gastroenterol Hepatol 24, 1484–1493 (2009).
- Kamar, N., Dalton, H. R., Abravanel, F. & Izopet, J. Hepatitis E Virus Infection. (2014) doi:10.1128/CMR.00057-13.
- Huang, S., Zhang, X., Jiang, H., Yan, Q. & Ai, X. Profile of Acute Infectious Markers in Sporadic Hepatitis E. PLoS One 5, 13560 (2010).
- Grandadam, M. et al. Evidence for hepatitis E virus quasispecies. Journal of General Virology 85, 3189–3194 (2004).
- Huang, F. F. et al. Detection by Reverse Transcription-PCR and Genetic Characterization of Field Isolates of Swine Hepatitis E Virus from Pigs in Different Geographic Regions of the United States. J Clin Microbiol 40, 1326 (2002).
- Kamar, N., Dalton, H. R., Abravanel, F. & Izopet, J. Hepatitis E virus infection. Clin Microbiol Rev 27, 116–138 (2014).
- Li, T. C. et al. Hepatitis E Virus Transmission from Wild Boar Meat. Emerg Infect Dis 11, 1958 (2005).
- Djilocalisse Sadio, B. et al. First hepatitis E outbreak in Southeastern Senegal The Rapid proliferation of traditional gold mining sites in the. 11 & Amadou Alpha Sall 11, 11.
- Perez, F. APPLICATION OF A DISTRIBUTED HYDROLOGIC MODEL FOR THE APPLICATION OF A DISTRIBUTED HYDROLOGIC MODEL FOR THE ANALYSIS OF LAND USE CHANGE IN KEDOUGOU, SENEGAL ANALYSIS OF LAND USE CHANGE IN KEDOUGOU, SENEGAL. (2019) doi:10.37099/mtu.dc.etdr/901.
- Benjelloun, S. et al. Seroepidemiological study of an acute hepatitis E outbreak in Morocco. Res Virol 148, 279–287 (1997).
- Kamar, N. et al. Hepatitis E. The Lancet 379, 2477–2488 (2012).
- Elduma, A. H. & Osman, W. M. Dengue and hepatitis E virus infection in pregnant women in Eastern Sudan, a challenge for diagnosis in an endemic area. Pan African Medical Journal-ISSN 19, 1937–8688 (2014).
- Diouara, A. A. M. et al. Hepatitis E Virus Seroprevalence and Associated Risk Factors in Pregnant Women Attending Antenatal Consultations in Senegal. Viruses 2022, Vol. 14, Page 1742 14, 1742 (2022).
- Joon, A., Rao, P., Shenoy, S. M. & Baliga, S. Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis. Indian J Med Microbiol 33 Suppl, S102–S105 (2015).
- Patel, R. C., Kamili, S. & Teshale, E. Hepatitis E virus infections in children age 0-15, Uganda outbreak, 2007. J Clin Virol 73, 112–114 (2015).
- Hughes, J. M., Wilson, M. E., Teshale, E. H., Hu, D. J. & Holmberg, S. D. The Two Faces of Hepatitis E Virus. doi:10.1086/653943.
- Purcell, R. H. & Emerson, S. U. Hepatitis E: An emerging awareness of an old disease. J Hepatol 48, 494–503 (2008).
- Tsarev, S. A. et al. Experimental Hepatitis E in Pregnant Rhesus Monkeys: Failure to Transmit Hepatitis E Virus (HEV) to Offspring and Evidence of Naturally Acquired Antibodies to HEV. J Infect Dis 172, 31–37 (1995).
- Nimgaonkar, I., Ding, Q., Schwartz, R. E. & Ploss, A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol 15, 96–110 (2018).



| District | Village | Total number of analysed samples | IgG Seroprevalence n (%) |
Total number of analysed sample | IgM Seroprevalence n (%) |
Death (n = 8) |
Pregnant women (n= 4) | |
| p--value | ||||||||
| Kédougou | Bandafassi | 29 | 8 (27,6) | 29 | 08 (27,6) | 0 | 0 | 1.88x 10-6 |
| Bantaco | 202 | 54 (26,7) | 202 | 52 (25,7) | 0 | 0 | ||
| Baytilaye | 15 | 8 (53,3) | 15 | 11 (73,3) | 0 | 0 | ||
| Kédougou | 233 | 49 (21,0) | 233 | 86 (36.9) | 3 | 2 | ||
| Laminya | 5 | 3 (60,0) | 5 | 02 (40,0) | 0 | 0 | ||
| Tenkoto | 134 | 40 (29,8) | 134 | 60 (44.8) | 0 | 0 | ||
| Thiokoye | 1 | 1 (100,0) | 2 | 01 (50,0) | 0 | 0 | ||
| Total | 619 | 163(26,3) | 620 | 220(35,5) | 3 | 2 | ||
| Saraya | Kharakhena | 101 | 48 (47,5) | 101 | 53 (52.5) | 2 | 1 | 0.043 |
| Sabodala | 11 | 9 (81,8) | 12 | 11 (91.7) | 1 | 0 | ||
| Saraya | 33 | 20 (60,6) | 33 | 25 (75.8) | 2 | 1 | ||
| Total | 145 | 77(53,1) | 146 | 89(70,0) | 5 | 2 | ||
| Salemata | Salemata | 12 | 8(66,7) | 12 | 10 (83.3) | 0 | 0 | |
| Total | 12 | 8(66,7) | 12 | 10 (83.3) | 0 | 0 |
| IgM | IgG | |||
|---|---|---|---|---|
| n (%) | p-value | n (%) | p-value | |
| Age group (years old) | ||||
| ˂15 | 83(25) | 0.05976 | 49(19,5) | 0.05592 |
| 16-30 | 159(47,9) | 121(48,2) | ||
| 31-45 | 65(19,6) | 57(22,7) | ||
| >45 | 25(7,5) | 24(9,6) | ||
| Total | 332 (100) | 251(100) | ||
| Sex distribution | ||||
| M | 227(68,6) | 0.01907 | 189 (75,3) | 4.496x10-6 |
| F | 104(31,4) | 62 (24,7) | ||
| Total | 331(100) | 251(100) | ||
| Suspected cases (n= 290) | Number of positive individuals n (%) | p-value |
|---|---|---|
| IgG+ | 123 (35.7) | 2.2x10-16 |
| IgM+ | 185 (63.8) | |
| IgM+/ IgG+ | 108 (37.2) | |
| Contacts (n= 470) | ||
| IgG+ | 119 (25.3) | |
| IgM+ | 141(30) | 2.2x10-16 |
| IgM+/ IgG+ | 67 (14.25) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).